Presidents' Award of Distinction for Team Science

The Presidents’ Award of Distinction for Team Science, conferred by the Presidents of the academic institutions of the Georgia Clinical and Translational Science Alliance (Georgia CTSA), recognizes and promotes excellence in multi-disciplinary research teams within the Georgia CTSA. This award will be presented to an outstanding multi-disciplinary research team in recognition of its innovative and impactful research that has, or will likely, advance clinical and translational science and positively impact human health. 

The recipient of the President’s Award of Distinction for Team Science will receive $5,000 towards their team science research program. Teams will be recognized at the 2023 Southeast Regional Clinical and Translational Conference (March 1-3, 2023).

Application Deadline: Nominations will be accepted through October 24, 2022.  

Application Details

Award Eligibility

  1. Each research team must have one or more representatives from a Georgia CTSA partner (Emory University, Georgia Institute of Technology, Morehouse School of Medicine, and/or the University of Georgia).
  2. Teams must be multi-disciplinary with representation from at least two different disciplines. In addition, diversity in terms of race, gender, institution, rank, etc. is strongly encouraged. 
  3. Research activities must be clinical or translational in nature and make a positive impact on human health.
  4. Teams are not eligible if applied to the 2023 Team Science Award of Distinction for Early Stage Research Teams.


Teams may self-nominate or be nominated by a faculty member or administrator from a Georgia CTSA partner institution.

A concise, two-page (maximum) narrative describing the team’s research, the impact on individual and/or community health, and a description of each team member’s substantive and quantifiable contributions to the team are required for each nomination. The narrative should emphasize specific features of the team that represent innovative, high-functioning teamwork and synergy and how these features have advanced their respective field(s).

The primary criterion for evaluation will be the team’s ability to demonstrate innovative, high-functioning teamwork and synergy in the narrative. Teams will also be evaluated using the following criteria.  It is not necessary to achieve every criterion below, as different teams will have different outcomes.

Evidence of high quality, productive teamworkShared abstracts, publications or scholarly works at any stage (e.g., submitted, in press, in revision) involving 2 or more team members, shared mentoring responsibilities, shared grant applications, shared resources, etc.)
Evidence of impactUse of team’s research outputs/innovations by peers (e.g., citations, use of the models/methods developed, contribution to theory/modeling methodology or school of thought). Additional evidence may include science prizes or patents. 

Innovation in teamwork

Evidence of novel approaches to ensuring high functioning of the team (e.g., use of team-oriented collaborative tools, development of novel methods for team collaboration)
Evidence of potential impact on health of individuals or communitiesClinical protocols, population studies, evidence-based policies citing team’s research outputs, public prizes, membership to advisory councils for civic organizations, trainings for professionals, practice guides, formal guidelines, executive summaries, tool kits, contributions to public debate or appearances as media experts (webinars, podcasts, briefs), development of medical technologies

Submission Instructions

All submissions must be emailed to and include the following:
  • Nomination letter (maximum of two pages)
  • A list of all members of the team and their professional titles and affiliations
  • A 2- 3 sentence explanation/description of your team's research
  • A description of each members role and what expertise they bring to the team  
  • Optional supporting documents, i.e., publications, brochures, examples of innovative teamwork or synergy, etc. (maximum of 5 pages total)

Selection Process

The Executive Council of the Georgia CTSA will review all nominations and make a recommendation to the University Presidents.

The Georgia Clinical & Translational Science Alliance (Georgia CTSA) is an inter-institutional magnet that concentrates basic, translational, and clinical research investigators, community clinicians, professional societies, and industry collaborators in dynamic clinical and translational research projects. Emory engaged three of its close academic partners - Morehouse School of Medicine (MSM), Georgia Institute of Technology (Georgia Tech), and the University of Georgia (UGA) - to form the Georgia CTSA. This partnership, a strategic multi-institutional alliance, offers compelling, unique, and synergistic advantages to research and patients statewide. Learn more about Georgia CTSA.